| leukocyte differentiation | GO:0002521 | 342 | 0.454 | Mouse |
| axon guidance | GO:0007411 | 141 | 0.385 | |
| neuron projection guidance | GO:0097485 | 141 | 0.371 | |
| central nervous system vasculogenesis | GO:0022009 | 3 | 0.340 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.313 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.312 | |
| muscle tissue development | GO:0060537 | 308 | 0.304 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.287 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.282 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.257 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.247 | |
| regionalization | GO:0003002 | 337 | 0.243 | |
| axonogenesis | GO:0007409 | 274 | 0.227 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.225 | |
| mapk cascade | GO:0000165 | 281 | 0.224 | |
| nephron development | GO:0072006 | 109 | 0.218 | |
| forebrain development | GO:0030900 | 302 | 0.215 | |
| gland development | GO:0048732 | 330 | 0.205 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.203 | |
| hindbrain formation | GO:0021576 | 1 | 0.176 | |
| regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation | GO:2000079 | 1 | 0.171 | |
| amine metabolic process | GO:0009308 | 45 | 0.171 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.169 | |
| uterus morphogenesis | GO:0061038 | 2 | 0.164 | |
| establishment of organ orientation | GO:0048561 | 1 | 0.164 | |
| t cell activation | GO:0042110 | 289 | 0.163 | Mouse |
| protein processing | GO:0016485 | 163 | 0.159 | |
| urogenital system development | GO:0001655 | 261 | 0.152 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.151 | |
| oxygen homeostasis | GO:0032364 | 2 | 0.150 | |
| spemann organizer formation | GO:0060061 | 2 | 0.149 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.149 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.145 | |
| kidney epithelium development | GO:0072073 | 121 | 0.145 | |
| chemotaxis | GO:0006935 | 247 | 0.142 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.142 | |
| renal system development | GO:0072001 | 225 | 0.142 | |
| digestive system development | GO:0055123 | 200 | 0.140 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.140 | |
| cellular homeostasis | GO:0019725 | 240 | 0.137 | |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.137 | |
| central nervous system morphogenesis | GO:0021551 | 2 | 0.134 | |
| paraxial mesodermal cell differentiation | GO:0048342 | 2 | 0.132 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.131 | |
| protein maturation | GO:0051604 | 176 | 0.131 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.129 | |
| midbrain hindbrain boundary maturation | GO:0021732 | 1 | 0.128 | |
| developmental maturation | GO:0021700 | 193 | 0.127 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.127 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.126 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.124 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.124 | |
| gtp catabolic process | GO:0006184 | 143 | 0.124 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.123 | |
| regulation of secretion | GO:0051046 | 274 | 0.118 | |
| paraxial mesodermal cell fate commitment | GO:0048343 | 2 | 0.117 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.116 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.116 | |
| cervix development | GO:0060067 | 2 | 0.116 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.115 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.114 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.112 | |
| regulation of cell activation | GO:0050865 | 289 | 0.111 | Mouse |
| extracellular structure organization | GO:0043062 | 148 | 0.110 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.110 | |
| positive regulation of anagen | GO:0051885 | 1 | 0.107 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.106 | |
| protein catabolic process | GO:0030163 | 221 | 0.106 | |
| skeletal system development | GO:0001501 | 356 | 0.105 | |
| regulation of ras gtpase activity | GO:0032318 | 88 | 0.105 | |
| skin development | GO:0043588 | 220 | 0.104 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.103 | |
| lateral sprouting involved in mammary gland duct morphogenesis | GO:0060599 | 2 | 0.102 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.101 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.101 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.101 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.100 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.099 | |
| regulation of cell migration | GO:0030334 | 219 | 0.099 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.099 | |
| negative regulation of neuron differentiation | GO:0045665 | 101 | 0.097 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.096 | |
| kidney development | GO:0001822 | 213 | 0.096 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.096 | Mouse |
| renal outer medulla development | GO:0072054 | 2 | 0.095 | |
| metanephric loop of henle development | GO:0072236 | 4 | 0.093 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.092 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.092 | |
| mesenchymal cell development | GO:0014031 | 93 | 0.092 | |
| response to peptide | GO:1901652 | 136 | 0.092 | |
| negative regulation of testosterone biosynthetic process | GO:2000225 | 1 | 0.091 | |
| non canonical wnt signaling pathway via jnk cascade | GO:0038031 | 3 | 0.090 | |
| limbic system development | GO:0021761 | 72 | 0.089 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.089 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.089 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.088 | |
| biomineral tissue development | GO:0031214 | 64 | 0.087 | |
| regulation of transforming growth factor beta2 production | GO:0032909 | 2 | 0.087 | |
| mesenchymal cell differentiation | GO:0048762 | 107 | 0.086 | |
| lung induction | GO:0060492 | 3 | 0.086 | |
| female gamete generation | GO:0007292 | 74 | 0.085 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.085 | |
| response to growth factor | GO:0070848 | 198 | 0.085 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.085 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.084 | |
| tissue remodeling | GO:0048771 | 102 | 0.082 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.082 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.082 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.081 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.081 | Mouse |
| cell fate commitment | GO:0045165 | 210 | 0.081 | |
| canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation | GO:0044343 | 1 | 0.081 | |
| cerebellum formation | GO:0021588 | 1 | 0.081 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.080 | |
| establishment of anatomical structure orientation | GO:0048560 | 1 | 0.080 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.080 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.079 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.079 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.079 | |
| positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation | GO:2000081 | 1 | 0.079 | |
| locomotory behavior | GO:0007626 | 195 | 0.078 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.078 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.077 | |
| non canonical wnt signaling pathway via mapk cascade | GO:0038030 | 3 | 0.077 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.077 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.076 | |
| positive regulation of leukocyte differentiation | GO:1902107 | 86 | 0.075 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.075 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.074 | |
| positive regulation of epithelial cell proliferation involved in lung morphogenesis | GO:0060501 | 3 | 0.074 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.074 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.073 | |
| mesoderm formation | GO:0001707 | 62 | 0.073 | |
| regulation of cell motility | GO:2000145 | 236 | 0.073 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.073 | Mouse |
| ubiquitin dependent smad protein catabolic process | GO:0030579 | 2 | 0.072 | |
| nephron epithelium morphogenesis | GO:0072088 | 68 | 0.072 | |
| columnar cuboidal epithelial cell differentiation | GO:0002065 | 82 | 0.072 | |
| regulation of ion transport | GO:0043269 | 215 | 0.071 | |
| spemann organizer formation at the anterior end of the primitive streak | GO:0060064 | 1 | 0.071 | |
| mesonephric duct morphogenesis | GO:0072180 | 4 | 0.071 | |
| respiratory tube development | GO:0030323 | 167 | 0.071 | |
| forebrain cell migration | GO:0021885 | 58 | 0.070 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.069 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.069 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.069 | |
| regulation of skeletal muscle fiber development | GO:0048742 | 36 | 0.069 | |
| wnt signaling pathway calcium modulating pathway | GO:0007223 | 2 | 0.068 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.067 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.067 | |
| negative regulation of prostatic bud formation | GO:0060686 | 4 | 0.066 | |
| ovulation | GO:0030728 | 15 | 0.066 | |
| endothelial cell migration | GO:0043542 | 44 | 0.065 | |
| mesonephric duct formation | GO:0072181 | 2 | 0.065 | |
| leukocyte apoptotic process | GO:0071887 | 71 | 0.065 | |
| epidermis development | GO:0008544 | 187 | 0.065 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.065 | |
| t cell proliferation | GO:0042098 | 120 | 0.064 | |
| planar cell polarity pathway involved in outflow tract morphogenesis | GO:0061347 | 2 | 0.063 | |
| digestive tract development | GO:0048565 | 190 | 0.063 | |
| cation homeostasis | GO:0055080 | 212 | 0.063 | |
| stem cell development | GO:0048864 | 219 | 0.063 | |
| midbrain hindbrain boundary maturation during brain development | GO:0022004 | 1 | 0.063 | |
| actin filament organization | GO:0007015 | 113 | 0.062 | |
| telencephalon development | GO:0021537 | 186 | 0.062 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.062 | |
| tertiary branching involved in mammary gland duct morphogenesis | GO:0060748 | 3 | 0.061 | |
| establishment of planar polarity involved in nephron morphogenesis | GO:0072046 | 1 | 0.061 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.061 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.061 | |
| germ cell development | GO:0007281 | 185 | 0.060 | |
| negative regulation of cell migration | GO:0030336 | 59 | 0.060 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.060 | |
| mammary gland morphogenesis | GO:0060443 | 54 | 0.060 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.059 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.059 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.059 | |
| myotube differentiation | GO:0014902 | 105 | 0.059 | |
| oviduct development | GO:0060066 | 3 | 0.059 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.059 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.059 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.059 | |
| proteasome mediated ubiquitin dependent protein catabolic process | GO:0043161 | 88 | 0.058 | |
| t cell differentiation | GO:0030217 | 174 | 0.058 | Mouse |
| epithelial cell development | GO:0002064 | 159 | 0.057 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.057 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.057 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.057 | |
| establishment or maintenance of polarity of embryonic epithelium | GO:0016332 | 1 | 0.057 | |
| rac protein signal transduction | GO:0016601 | 13 | 0.057 | |
| polarity specification of proximal distal axis | GO:0010085 | 2 | 0.056 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.056 | |
| wnt signaling pathway involved in forebrain neuroblast division | GO:0021874 | 2 | 0.056 | |
| stem cell differentiation | GO:0048863 | 268 | 0.056 | |
| lung field specification | GO:0060424 | 3 | 0.056 | |
| cell adhesion | GO:0007155 | 329 | 0.055 | |
| nephron epithelium development | GO:0072009 | 92 | 0.055 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.055 | |
| chromatin modification | GO:0016568 | 187 | 0.055 | |
| hair follicle development | GO:0001942 | 85 | 0.055 | |
| chromatin organization | GO:0006325 | 206 | 0.054 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.054 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.054 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.054 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.054 | |
| regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045898 | 2 | 0.054 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.053 | |
| mesoderm development | GO:0007498 | 100 | 0.053 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.053 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.053 | |
| renal tubule morphogenesis | GO:0061333 | 72 | 0.052 | |
| cell maturation | GO:0048469 | 127 | 0.052 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.052 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.052 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.052 | |
| oocyte differentiation | GO:0009994 | 35 | 0.052 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.052 | |
| foregut regionalization | GO:0060423 | 3 | 0.052 | |
| gliogenesis | GO:0042063 | 141 | 0.051 | |
| cochlea morphogenesis | GO:0090103 | 22 | 0.051 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.051 | |
| paramesonephric duct development | GO:0061205 | 3 | 0.051 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.051 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.051 | |
| adult behavior | GO:0030534 | 135 | 0.050 | |
| negative regulation of multi organism process | GO:0043901 | 68 | 0.050 | |
| membrane organization | GO:0061024 | 245 | 0.049 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.049 | |
| odontogenesis of dentin containing tooth | GO:0042475 | 66 | 0.049 | |
| regulation of kidney development | GO:0090183 | 40 | 0.048 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.048 | |
| formation of primary germ layer | GO:0001704 | 77 | 0.048 | |
| hair cycle | GO:0042633 | 90 | 0.047 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.047 | |
| cognition | GO:0050890 | 149 | 0.047 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.047 | |
| positive regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045899 | 2 | 0.047 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.047 | |
| renal vesicle induction | GO:0072034 | 3 | 0.047 | |
| positive regulation of rho gtpase activity | GO:0032321 | 41 | 0.047 | |
| transforming growth factor beta2 production | GO:0032906 | 2 | 0.046 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.046 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.046 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.046 | |
| glandular epithelial cell differentiation | GO:0002067 | 38 | 0.046 | |
| regulation of asymmetric cell division | GO:0009786 | 4 | 0.046 | |
| inner medullary collecting duct development | GO:0072061 | 2 | 0.046 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.045 | |
| positive regulation of ras gtpase activity | GO:0032320 | 65 | 0.045 | |
| outer medullary collecting duct development | GO:0072060 | 1 | 0.045 | |
| dendrite development | GO:0016358 | 115 | 0.045 | |
| histone modification | GO:0016570 | 159 | 0.045 | |
| response to acid chemical | GO:0001101 | 111 | 0.045 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.045 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.045 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.045 | |
| axis elongation involved in somitogenesis | GO:0090245 | 4 | 0.044 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.044 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.044 | |
| ear development | GO:0043583 | 200 | 0.044 | |
| compound eye development | GO:0048749 | 1 | 0.044 | |
| negative regulation of cell motility | GO:2000146 | 61 | 0.044 | |
| glial cell differentiation | GO:0010001 | 131 | 0.044 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.044 | |
| camera type eye development | GO:0043010 | 266 | 0.044 | |
| mammary gland epithelium development | GO:0061180 | 65 | 0.044 | |
| hypophysis morphogenesis | GO:0048850 | 3 | 0.043 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.043 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.043 | |
| mesonephric tubule morphogenesis | GO:0072171 | 63 | 0.043 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.043 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.043 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.043 | |
| planar cell polarity pathway involved in pericardium morphogenesis | GO:0061354 | 2 | 0.043 | |
| negative regulation of neuron projection development | GO:0010977 | 50 | 0.043 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.043 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.042 | |
| regulation of stress activated mapk cascade | GO:0032872 | 69 | 0.042 | |
| positive regulation of gtpase activity | GO:0043547 | 85 | 0.042 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.042 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.042 | |
| jnk cascade | GO:0007254 | 72 | 0.042 | |
| gonad development | GO:0008406 | 141 | 0.042 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.042 | |
| establishment of tissue polarity | GO:0007164 | 28 | 0.042 | |
| kidney rudiment formation | GO:0072003 | 3 | 0.042 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.041 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.041 | |
| response to peptide hormone | GO:0043434 | 127 | 0.041 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.041 | |
| exocrine system development | GO:0035272 | 45 | 0.041 | |
| positive regulation of gtp catabolic process | GO:0033126 | 85 | 0.041 | |
| regulation of interleukin 8 secretion | GO:2000482 | 2 | 0.041 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.041 | |
| regulation of neural precursor cell proliferation | GO:2000177 | 70 | 0.041 | |
| regulation of t cell differentiation | GO:0045580 | 83 | 0.041 | Mouse |
| transmission of nerve impulse | GO:0019226 | 76 | 0.041 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.041 | |
| protein localization to membrane | GO:0072657 | 108 | 0.041 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.041 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.040 | |
| negative regulation of lymphocyte activation | GO:0051250 | 91 | 0.040 | |
| wnt signaling pathway planar cell polarity pathway | GO:0060071 | 27 | 0.040 | |
| gas homeostasis | GO:0033483 | 3 | 0.040 | |
| regulation of myotube differentiation | GO:0010830 | 62 | 0.040 | |
| canonical wnt signaling pathway involved in regulation of cell proliferation | GO:0044340 | 3 | 0.040 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.040 | |
| primary neural tube formation | GO:0014020 | 95 | 0.040 | |
| regulation of system process | GO:0044057 | 200 | 0.040 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.040 | |
| epithelial tube formation | GO:0072175 | 130 | 0.040 | |
| muscle system process | GO:0003012 | 141 | 0.040 | |
| cell fate specification | GO:0001708 | 72 | 0.040 | |
| kidney morphogenesis | GO:0060993 | 83 | 0.040 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.040 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.040 | |
| calcium ion transmembrane transport | GO:0070588 | 85 | 0.039 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.039 | |
| maintenance of cell number | GO:0098727 | 3 | 0.039 | |
| renal inner medulla development | GO:0072053 | 3 | 0.039 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.039 | |
| regulation of ovulation | GO:0060278 | 3 | 0.039 | |
| somatotropin secreting cell differentiation | GO:0060126 | 4 | 0.038 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.038 | |
| lung development | GO:0030324 | 164 | 0.038 | |
| mesoderm morphogenesis | GO:0048332 | 64 | 0.038 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.038 | |
| pallium development | GO:0021543 | 120 | 0.038 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.038 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.038 | |
| skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration | GO:0014834 | 3 | 0.038 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.038 | |
| metanephros development | GO:0001656 | 79 | 0.038 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.037 | |
| positive regulation of lymphocyte proliferation | GO:0050671 | 70 | 0.037 | |
| neuron fate specification | GO:0048665 | 30 | 0.037 | |
| ossification | GO:0001503 | 216 | 0.037 | |
| fibroblast growth factor production | GO:0090269 | 4 | 0.037 | |
| neural tube development | GO:0021915 | 160 | 0.037 | |
| cellular response to peptide | GO:1901653 | 92 | 0.037 | |
| androgen biosynthetic process | GO:0006702 | 4 | 0.037 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.037 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.036 | |
| negative regulation of wnt signaling pathway | GO:0030178 | 73 | 0.036 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.036 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.036 | |
| positive regulation of muscle tissue development | GO:1901863 | 32 | 0.036 | |
| establishment of endothelial blood brain barrier | GO:0014045 | 3 | 0.036 | |
| myoblast differentiation involved in skeletal muscle regeneration | GO:0014835 | 3 | 0.036 | |
| wound healing | GO:0042060 | 157 | 0.036 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.036 | |
| inflammatory response | GO:0006954 | 244 | 0.035 | |
| cell recognition | GO:0008037 | 83 | 0.035 | |
| respiratory system development | GO:0060541 | 190 | 0.035 | |
| negative regulation of canonical wnt signaling pathway | GO:0090090 | 51 | 0.035 | |
| alpha beta t cell activation | GO:0046631 | 91 | 0.035 | Mouse |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.035 | |
| neuron migration | GO:0001764 | 122 | 0.035 | |
| positive regulation of response to wounding | GO:1903036 | 66 | 0.035 | |
| regulation of testosterone biosynthetic process | GO:2000224 | 2 | 0.035 | |
| cation transport | GO:0006812 | 399 | 0.035 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.034 | |
| lung epithelium development | GO:0060428 | 37 | 0.034 | |
| osteoclast differentiation | GO:0030316 | 62 | 0.034 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.034 | |
| regulation of cell growth | GO:0001558 | 91 | 0.034 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.034 | |
| immune effector process | GO:0002252 | 321 | 0.033 | |
| blastocyst development | GO:0001824 | 80 | 0.033 | |
| pituitary gland development | GO:0021983 | 38 | 0.033 | |
| myotube cell development | GO:0014904 | 60 | 0.033 | |
| angiogenesis | GO:0001525 | 201 | 0.033 | |
| neuron death | GO:0070997 | 154 | 0.033 | |
| gtp metabolic process | GO:0046039 | 144 | 0.033 | |
| nephron tubule morphogenesis | GO:0072078 | 68 | 0.033 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 93 | 0.033 | |
| ureteric bud development | GO:0001657 | 94 | 0.033 | |
| regulation of cardiac muscle tissue development | GO:0055024 | 31 | 0.033 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.033 | |
| lymphocyte apoptotic process | GO:0070227 | 54 | 0.033 | |
| negative regulation of cell morphogenesis involved in differentiation | GO:0010771 | 48 | 0.033 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.033 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.033 | |
| microtubule based process | GO:0007017 | 236 | 0.033 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.033 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.033 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.032 | |
| regulation of anagen | GO:0051884 | 1 | 0.032 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.032 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.032 | |
| negative regulation of androgen biosynthetic process | GO:2000180 | 1 | 0.032 | |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.032 | |
| epithelial to mesenchymal transition | GO:0001837 | 47 | 0.032 | |
| epithelial cell migration | GO:0010631 | 63 | 0.032 | |
| glucose transport | GO:0015758 | 56 | 0.032 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.031 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.031 | |
| morphogenesis of an epithelial sheet | GO:0002011 | 27 | 0.031 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.031 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.031 | |
| glucose homeostasis | GO:0042593 | 128 | 0.031 | |
| cerebral cortex development | GO:0021987 | 86 | 0.031 | |
| columnar cuboidal epithelial cell development | GO:0002066 | 29 | 0.031 | |
| neuron recognition | GO:0008038 | 25 | 0.031 | |
| gastrulation | GO:0007369 | 116 | 0.030 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.030 | |
| ventral spinal cord interneuron differentiation | GO:0021514 | 16 | 0.030 | |
| ear morphogenesis | GO:0042471 | 118 | 0.030 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.030 | |
| cellular amide metabolic process | GO:0043603 | 58 | 0.030 | |
| sensory perception | GO:0007600 | 245 | 0.030 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.030 | |
| olfactory bulb development | GO:0021772 | 30 | 0.030 | |
| positive regulation of interleukin 8 production | GO:0032757 | 2 | 0.030 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.030 | |
| renal tubule development | GO:0061326 | 87 | 0.030 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.030 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.029 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.029 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.029 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.029 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.029 | |
| regulation of reproductive process | GO:2000241 | 66 | 0.029 | |
| regulation of protein processing | GO:0070613 | 96 | 0.029 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.029 | |
| testosterone biosynthetic process | GO:0061370 | 2 | 0.029 | |
| learning or memory | GO:0007611 | 148 | 0.029 | |
| myoblast differentiation | GO:0045445 | 52 | 0.029 | |
| regulation of inositol trisphosphate biosynthetic process | GO:0032960 | 3 | 0.028 | |
| amide transport | GO:0042886 | 138 | 0.028 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.028 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.028 | |
| zygotic determination of anterior posterior axis embryo | GO:0007354 | 3 | 0.028 | |
| cop9 signalosome assembly | GO:0010387 | 2 | 0.028 | |
| regulation of protein complex assembly | GO:0043254 | 83 | 0.028 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.028 | |
| planar cell polarity pathway involved in heart morphogenesis | GO:0061346 | 3 | 0.028 | |
| alpha beta t cell differentiation | GO:0046632 | 69 | 0.028 | Mouse |
| regulation of multi organism process | GO:0043900 | 111 | 0.028 | |
| cell differentiation in spinal cord | GO:0021515 | 53 | 0.028 | |
| regulation of hormone secretion | GO:0046883 | 88 | 0.028 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.028 | |
| urinary bladder development | GO:0060157 | 5 | 0.028 | |
| regulation of myoblast differentiation | GO:0045661 | 29 | 0.028 | |
| positive regulation of transforming growth factor beta2 production | GO:0032915 | 2 | 0.028 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.028 | |
| positive regulation of transcription via serum response element binding | GO:0010735 | 1 | 0.027 | |
| memory | GO:0007613 | 58 | 0.027 | |
| interleukin 8 production | GO:0032637 | 4 | 0.027 | |
| regulation of jnk cascade | GO:0046328 | 62 | 0.027 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.027 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.027 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.027 | |
| protein oligomerization | GO:0051259 | 67 | 0.027 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.027 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 68 | 0.027 | |
| regulation of viral transcription | GO:0046782 | 3 | 0.027 | |
| regulation of interleukin 8 production | GO:0032677 | 3 | 0.027 | |
| planar cell polarity pathway involved in cardiac right atrium morphogenesis | GO:0061349 | 2 | 0.027 | |
| positive regulation of leukocyte proliferation | GO:0070665 | 73 | 0.027 | |
| cellular response to carbohydrate stimulus | GO:0071322 | 50 | 0.027 | |
| regulation of chondrocyte differentiation | GO:0032330 | 33 | 0.027 | |
| dorsal ventral axon guidance | GO:0033563 | 3 | 0.027 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.027 | |
| syncytium formation | GO:0006949 | 43 | 0.027 | |
| regulation of protein localization | GO:0032880 | 231 | 0.026 | |
| neural tube patterning | GO:0021532 | 43 | 0.026 | |
| ureteric bud morphogenesis | GO:0060675 | 62 | 0.026 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.026 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.026 | |
| nephric duct formation | GO:0072179 | 4 | 0.026 | |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.026 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.026 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.026 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.026 | |
| endocytosis | GO:0006897 | 168 | 0.026 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.026 | |
| b cell mediated immunity | GO:0019724 | 71 | 0.026 | |
| mesenchyme development | GO:0060485 | 152 | 0.026 | |
| response to monosaccharide | GO:0034284 | 67 | 0.026 | |
| male gamete generation | GO:0048232 | 285 | 0.026 | |
| cellular response to starvation | GO:0009267 | 57 | 0.026 | |
| stem cell maintenance | GO:0019827 | 130 | 0.026 | |
| regulation of peptide transport | GO:0090087 | 91 | 0.026 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.026 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.026 | |
| heart morphogenesis | GO:0003007 | 178 | 0.025 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.025 | |
| positive regulation of interleukin 8 secretion | GO:2000484 | 1 | 0.025 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.025 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.025 | |
| regulation of fibroblast growth factor production | GO:0090270 | 4 | 0.025 | |
| negative regulation of fibroblast growth factor production | GO:0090272 | 2 | 0.025 | |
